Document:

Exhibit 10.1

 Exhibit 10.1 
 FORM OF CONFIDENTIALITY, NON-DISCLOSURE AND NON-SOLICITATION AGREEMENT 
 In
consideration of and as a condition of my employment by S1 Corporation, a Delaware corporation (the “Company”, which term shall also include any subsidiaries and divisions of S1 Corporation), I hereby agree with the Company as follows:

  

	 	1.	Nondisclosure and Use of Proprietary Information. 

 (a) I will not at any time, whether during or after the termination of my employment, reveal to any person or entity any of the trade secrets or proprietary or confidential information of the Company, or
of any third party which the Company is under an obligation to keep confidential, including, but not limited to, information respecting inventions, products, product plans, designs, formulae, drawings, sketches, marketing and other plans, methods,
know-how, techniques, technology, systems, characters, processes, strategies, works of authorship, customer lists, user lists, vendor lists, content provider lists, supplier lists, pricing information, projects, notes, memoranda, reports, lists,
records, specifications, computer programs (including object code and source code), computer software and data base technologies, systems, structures and architectures (and related processes, algorithms, compositions, improvements, methods,
concepts, ideas, designs and information), data, documentation, budgets, plans, projections, forecasts, financial information and proposals in whatever form, tangible or intangible or other materials of any nature relating to any matter within the
scope of the business of the Company or concerning any of the dealings or affairs of the Company (collectively, “Proprietary Information”)), except as may be required in the course of performing my duties as an employee of the Company, and
I shall keep secret all matters entrusted to me and shall not use or attempt to use any such information in any manner except as may be required in the course of performing my duties as an employee of the Company. 

(b) As used herein, the term “Intellectual Property Rights” shall mean all industrial and intellectual property rights,
including, without limitation, patents, patent applications, patent rights, trademarks, trademark applications, trade names, service marks, service mark applications, copyrights, copyright applications or registrations, trade secrets, and trade
dress. 
 (c) The restrictions in Section 1(a) above shall not apply to: (i) information that at the time of
disclosure is in the public domain through no fault of mine; (ii) information received from a third party outside of the Company that was disclosed without a breach of any confidentiality obligation; (iii) information approved for release
by written authorization of the Company; or (iv) information that may be required by law or an order of any court, agency or proceeding to be disclosed. 
 (d) During my employment I shall not take, use or permit to be used any Proprietary Information otherwise than for the benefit of the Company. I shall not, after the termination of my employment, use or
permit to be used any Proprietary Information, it being agreed that all Proprietary Information shall be and remain the sole and exclusive property of the Company and that immediately upon the termination of my employment, I shall deliver all copies
of Proprietary Information to the Company at its main office. 

 (e) While I am employed at the Company, I will not disclose to the Company, use, or induce
the Company to use, any confidential, proprietary or trade secret information of others. 
 (f) I will not enter into any
agreement that conflicts with the terms of this Agreement. 
  

	 	2.	Assignment of Developments. 

 (a) If at any time or times during my employment by the Company I shall (either alone or with others) make, conceive, invent, discover or reduce to practice or author any Proprietary Information
whatsoever or otherwise obtain any interest therein (whether or not patentable or registrable under copyright or similar statutes or subject to analogous protection) (herein called “Developments”) that (i) relates to the business of
the Company or any customer of or supplier to the Company or any of the products or services being developed, manufactured, sold or provided by the Company or which may be used in relation therewith, (ii) results from tasks assigned me by the
Company or (iii) results from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company, such Developments and the benefits thereof shall immediately become the sole and absolute
property of the Company and its assigns, and I shall promptly disclose to the Company (or any persons designated by it) each such Development and hereby assign any rights, including Intellectual Property Rights, I may have or acquire in the
Developments and benefits and/or rights resulting therefrom to the Company and its assigns without further compensation and shall communicate, without cost or delay, and without publishing the same, all available information relating thereto (with
all necessary plans and models) to the Company. 
 (b) I will, during my employment and at any time thereafter, at the request
and cost of the Company, sign, execute, make and do all such deeds, documents; acts and things as the Company and its duly authorized agents may reasonably require: 
  

	 	(i)	to apply for, obtain and vest in the name of the Company alone (unless the Company otherwise directs) letters patent, copyrights or other analogous protection in any
country throughout the world for any Developments that I make, conceive, invent, discover, reduce to practice or author during the term of my employment by the Company, and when so obtained or vested to renew and restore the same;

  

	 	(ii)	to defend any actions or opposition proceedings in respect of such applications and any opposition proceedings or petitions or applications for revocation of such
letters patent, copyright or other analogous protection; and 

  

	 	(iii)	to bring any action to enforce any rights in any Developments. 

 (c) In the event the Company is unable, after reasonable effort, to secure my signature on
any patent application, copyright application or other analogous document or instrument relating to a Development described in Section 2(b) above, whether because of my physical or mental incapacity or for any other reason whatsoever, I hereby
irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney-in-fact, to act for and in my behalf and stead to execute and file any such application or other document or instrument and to do all
other lawfully permitted acts to further the prosecution and issuance of any such letters patent, copyright and other analogous protection thereon with the same legal force and effect as if executed by me. 

 

	 	3.	Non-Solicitation. 

(a) While I am employed at the Company and for a period of 24 months after termination of my employment for any reason (whether voluntary
or involuntary), I will not, directly or indirectly, solicit, recruit or hire any employee of the Company to work for a third party other than the Company or otherwise solicit, entice or induce any employee to materially breach any agreement between
such employee and the Company of which I have knowledge. 
 (b) While I am employed by the Company and for a period of 24 months
after termination of my employment for any reason (whether voluntary or involuntary) other than because of non-renewal of my employment agreement by the Company, I will not, directly or indirectly, solicit, entice or induce any Customer (as defined
below) of the Company to (i) become a Customer of any other person or entity engaged in any material respect in any business activity that competes with any material business activity conducted by the Company at any time during the period of my
employment with the Company, or any business activity planned by the Company at any time during the period of my employment with the Company that the Company reasonably believes will be a material business activity in the future (other than such a
planned activity that has been abandoned by the Company) or (ii) cease doing business with the Company, and I will not assist any person or entity in taking any action described in the foregoing clauses (i) and (ii). For purposes of this
paragraph (c), a “Customer” of the Company means any person, corporation, partnership, trust, division, business unit, department or agency which, at the time of determination or within one year prior thereto, shall be or shall have been a
material customer, distributor or agent of the Company or shall be or shall have been contacted by the Company for the purpose of soliciting it to become a material customer, distributor or agent of the Company. 

 

	 	4.	Representations and Warranties. 

 I hereby represent and warrant to the Company as follows: 
 (a) I have returned
all property and confidential, proprietary or trade secret information belonging to all prior employers and clients, if any, to the extent that such property and confidential, proprietary or trade secret information was required to be returned, and
in any event, have not exposed or brought to the Company any such information, and no such information has been or will be used in connection with rendering any of the services hereunder. 

 (b) The performance of the terms of this Agreement will not breach or conflict with any
agreement to which I am a party. 
 (c) Except as I have disclosed in writing to the Company, I am not bound by the terms of any
agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of my employment with the Company or to refrain from competing, directly or indirectly,
with the business or such employer or any other party. 
  

	 	5.	Equitable Relief. 

I agree that any breach of this Agreement by me will cause irreparable damage to the Company and that in the event of such breach the
Company shall have, in addition to any and all remedies at law, the right to an injunction, specific performance or other equitable relief to prevent the violation of my obligations hereunder. Nothing herein contained shall be construed as
prohibiting the Company from pursuing any other remedy available for such breach or threatened breach. The prevailing party in any litigation arising under this Agreement shall be entitled to recover his or its attorneys’ fees and expenses in
addition to all other available remedies. 
  

	 	6.	No Right to Continued Employment. 

 I understand that this Agreement does not create an obligation on the Company or any other person or entity to continue my employment or to exploit any Developments. 

 

	 	7.	Waivers. 

 Any
waiver by the Company of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach of such provision or any other provision hereof. 

 

	 	8.	Acknowledgment; Severability. 

 I hereby acknowledge that the type and periods of restriction imposed in the provisions of this Agreement are fair and reasonable and are reasonably required for the protection of the Company’s
proprietary information and the goodwill associated with the business of the Company. I hereby further acknowledge that the provisions of this Agreement shall be enforced to the fullest extent permissible under the laws and public policies applied
in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated to be invalid or unenforceable, such provision shall be deemed amended to delete therefrom the portion thus
adjudicated to be invalid or unenforceable, such deletion to apply only with respect to the operation of such provision in the particular jurisdiction in which such adjudication is made. In addition, if any one or more of the provisions contained in
this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be the extent compatible with the applicable law, as it shall then appear. Any provision of this Agreement which is
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. 

	 	9.	Survival of Obligations. 

 My obligations under this Agreement shall survive the termination of my employment regardless of the manner of such termination and shall be binding upon my heirs, executors, administrators and legal
representatives. 
  

	 	10.	Assignment. 

 The
Company shall have the right to assign this Agreement to its successors and assigns, and all covenants and agreements hereunder shall inure to the benefit of and be enforceable by said successors or assigns. 

 

	 	11.	Governing Law. 

This Agreement will be governed by and construed in accordance with the laws of the State of Georgia applicable to contracts made and to
be performed wholly therein (without regard to principles of conflicts of laws). 
 IN WITNESS WHEREOF, the undersigned has
executed this Confidentiality, Non-Disclosure and Non-Solicitation Agreement as of the      day of                 ,
        . 
  

							
		 		 	  

		 		 	Signature
				
		 		 	Name:	 	  

			
		 		 	  

			
		 		 	  

		 		 	Address
			
	Agreed to and Accepted:	 		 	
			
	S1 CORPORATION	 		 	
				
	By:Exhibit 10.2

 Exhibit 10.2 
 Amendment to Agreement 
 This Amendment to Agreement (this
“Amendment”), dated effective as of February 10, 2012 (the “Effective Date”), is by and between S1 Corporation (the “Company”) and Johann Dreyer (the “Executive”). 

RECITALS 

A. The Company and the Executive entered into an Agreement dated December 24, 2008 (the “Agreement”); 

B. The Company and the Executive entered into a Confidentiality, Non-Disclosure and Non-Solicitation Agreement dated December 13,
2006 (the “Covenant Agreement”); and 
 C. The Company and the Executive wish to amend (i) the Agreement in
accordance with the terms and conditions set forth below and (ii) the Covenant Agreement in accordance with the terms and conditions of that separate amendment to the Covenant Agreement of equal date herewith. 

NOW, THEREFORE, in consideration of these premises and mutual agreements, including the amendment to the Covenant Agreement of equal date
herewith, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 1. Section 3(d)(A) of the Agreement shall be amended and restated in its entirety to read as follows: 

(A) pay You (i) in equal installments as of the 1st and 15th day of each month during the 12-month period commencing on Your date of termination (the “Severance
Period”), an aggregate amount equal to three (3) times Your then current base salary, (ii) within thirty (30) days following Your date of termination, a pro rata portion of the annual bonus that would have been payable to You for
the calendar year of termination if Your employment had not terminated (calculated based upon actual results through Your date of termination and based upon budget for the remainder of the period and pro rated for the portion of the year during
which You were employed), and (iii) within thirty (30) days following Your date of termination, an aggregate amount equal to three (3) times the average annual bonus actually paid or payable to You for the immediately prior three
calendar years, provided, however, that the amount calculated as Your average annual bonus shall not exceed Your target annual bonus as of January 2011, provided, further, however, that if upon the date any payment is due pursuant to
this Section 3(d)(A) the conditions of Section 5 have not been met, such payment will not be made upon the date specified above but instead will be made on the first payroll date following the date on which such conditions have been met;

 2. Section 3(d)(B) of the Agreement shall be amended and restated in its entirety to read as follows: 

(B) reimburse You for any COBRA premiums You pay for You and any of Your dependents during the Severance Period, if and to
the extent You and/or Your dependents are entitled to COBRA continuation coverage under the Company’s major medical group plan in which You and/or Your dependents participated immediately prior to the date of termination, provided,
however, that (i) notwithstanding anything in this subsection to the contrary, all other terms and provisions of the Company major medical group plan governing Your rights and Your dependent’s rights under COBRA shall apply and
(ii) such reimbursement will not be made until the conditions of Section 5 have been met and any reimbursement that would have been made prior to the conditions of Section 5 being met but for this provision will instead be made on the
first payroll date following the date on which the conditions of Section 5 have been met; and 
 3. Section 5 of the
Agreement shall be amended and restated in its entirety to read as follows: 
 5. Release
Obligations. The Company’s obligation to pay You the separation payments set forth in Section 3(d) shall be conditioned upon (a) Your execution, prior to the 60th day following Your date 

 
of termination, and compliance with a valid, binding and irrevocable Separation & Release Agreement in a form prepared by the Company in its sole and absolute discretion, which includes,
but is not limited to, Your release of the Company and its officers, directors, employees, stockholders and affiliates from any and all liability and claims of any kind and Your confirmation of the Company’s right to continued performance by
You of Your obligations under the Covenants Agreement (defined below) during the period following the termination of Your employment and (b) the expiration of any applicable revocation period during the 60-day period following Your date of
termination without You revoking such Separation & Release Agreement. 
 4. Section 7(e) of the Agreement shall be
amended and restated in its entirety to read as follows: 
 (e) “Good Reason” shall exist if (i) the
Company, without Your written consent (a) materially reduces the scope of Your duties (including, without limitation, any merger, consolidation, reorganization, sale of stock or assets or other transaction that results in You reporting to
anyone in a position having less authority than the person to whom You reported immediately before such transaction, or any failure of the parent corporation of any controlled group of corporations that includes the Company, if the Company is not
such parent corporation, to offer You a position with such parent corporation involving the same or substantially equivalent duties as Your then current position with the Company), or (b) requires You to relocate to a place more than 50 miles
from Norcross, Georgia to perform Your duties; (ii) You provide written notice to the Company of such action within 90 days of the occurrence thereof and provide the Company with 30 days to remedy such action (the “Cure Period”);
(iii) the Company fails to remedy such action within the Cure Period; and (iv) You elect to resign within 30 days of the expiration of the Cure Period; 
 5. Section 9 of the Agreement shall be amended and restated in its entirety to read as follows: 
 9. Limitation on Parachute Payments. Notwithstanding any other provision of this Agreement or of any other agreement, contract, or understanding heretofore or hereafter entered into by You with the
Company or any subsidiary or affiliate, except an agreement, contract, or understanding hereafter entered into that expressly modifies or excludes application of this Section (an “Other Agreement”), and notwithstanding any formal or
informal plan or other arrangement for the direct or indirect provision of compensation to You (including groups or classes of participants or beneficiaries of which You are a member), whether or not such compensation is deferred, is in cash, or is
in the form of a benefit to or for You (a “Benefit Arrangement”), if You are a “disqualified individual,” as defined in Section 280G(c) of the Code, no payment or benefit shall be made or provided to You or become vested,
exercisable or payable, as applicable, (i) to the extent that such payment, right to exercise, vesting, or other benefit, taking into account all other payments, rights, or benefits to or for You, or becoming vested, exercisable or payable, as
the case may be, under this Agreement, all Other Agreements and all Benefit Arrangements, would cause any such payment, right to exercise, vesting or other benefit to which You are or would be entitled under this Agreement to be considered a
“parachute payment” within the meaning of Section 280G(b)(2) of the Code as then in effect (a “Parachute Payment”) and (ii) if, as a result of receiving a Parachute Payment, the aggregate after-tax amounts
received by You under this Agreement, all Other Agreements, and all Benefit Arrangements would be less than the maximum after-tax amount that could be received by You without causing any such payment, right to exercise, vesting or other benefit to
be considered a Parachute Payment. In the event that the receipt of any such payment, right to exercise, vesting, or other benefit under this Agreement, in conjunction with all other rights, payments, or benefits to or for You under any Other
Agreement or any Benefit Arrangement would cause You to be considered to have received a Parachute Payment under this Agreement that would have the effect of decreasing the after-tax amount received by You as described in clause (ii) of the
preceding sentence, then the payment, right to exercise, vesting, or other benefit under this Agreement will be reduced or eliminated so as to avoid having the payment, right to exercise, vesting, or other benefit under this Agreement be deemed to
be a Parachute Payment. The reduction or elimination of payments, rights to exercise, vesting, or other benefits hereunder pursuant to the preceding sentence, if applicable, shall be made by first reducing or eliminating the payments under
Section 3(d)(A) and then Section 3(d)(B) hereof, and then by reducing or eliminating the value of the benefits contemplated by Sections 3(d)(C) and 4 hereof, and in any event shall be made in such a manner as to maximize the economic
present value as of the date of the Change in Control for purposes of 

 
Section 280G of the Code (as determined by the Accounting Firm (as defined below) using the discount rate required by Section 280G(d)(4) of the Code) of all rights, payments and
benefits hereunder. All determinations required to be made under this Section, including whether and when a reduction in rights, payments or benefits (or the vesting or exercisability thereof) is required and the amount of such reduction and the
assumptions to be utilized in arriving at such determination, shall be made by PricewaterhouseCoopers LLP or such other certified public accounting firm reasonably acceptable to the Company as may be designated by You in writing (the
“Accounting Firm”) which shall provide detailed supporting calculations both to the Company and You within 15 business days of the receipt of notice from You or the Company. In the event that the Accounting Firm is serving as accountant or
auditor for the Company or any individual, entity or group effecting a change in the ownership or effective control of the Company (within the meaning of Section 280G of the Code), You shall appoint another nationally recognized accounting firm
that is reasonably acceptable to the Company to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm shall be borne solely by the
Company. Any determination by the Accounting Firm shall be binding upon the Company and You. 
 6. Section 10 of the
Agreement shall be amended and restated in its entirety to read as follows: 
 10. Entire Agreement. This
Agreement, as amended, constitutes the entire agreement between the Parties concerning the subject matter of this Agreement and supersedes any prior communications, agreements or understandings, whether oral or written, between You and the Company
relating to severance payments of any type or nature, including without limitation, the Prior Agreement. Other than the terms of this Agreement, no other representation, promise or agreement has been made with You to cause You to sign this
Agreement. 
 7. Section 11 of the Agreement shall be amended and restated in its entirety to read as follows: 

11. Confidentiality, Non-Disclosure and Non-Solicitation Agreement. By execution of this Agreement, the Parties
acknowledge the continuing validity and effectiveness of the Confidentiality, Non-Disclosure and Non-Solicitation Agreement dated as of December 18, 2006 and as amended as of February 10, 2012 (the “Covenants Agreement”).

 8. Except as provided above, the terms and conditions of the Agreement shall remain unchanged and shall remain in full force
and effect. Capitalized terms used but not defined herein shall have the meaning set forth in the Agreement. 
 IN WITNESS
WHEREOF, the parties hereto have executed this Amendment effective as of the Effective Date. 
  

			
		 	S1 CORPORATION
		
	By:	 	 /s/ Gregory D. Orenstein

		 	Gregory D. Orenstein
		 	SVP, Chief Legal Officer and Secretary
		
		 	THE EXECUTIVE
		
		 	 /s/ Johann Dreyer

		 	Johann Dreyer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]